Yuhan Corporation (KRX:000100)
South Korea · Delayed Price · Currency is KRW 100,300
+1,600 (1.62%)
At close: Mar 20, 2026
Yuhan Market Cap
Yuhan has a market cap or net worth of 7.45 trillion as of March 20, 2026. Its market cap has decreased by -18.68% in one year.
Market Cap
7.45T
Enterprise Value
7.47T
Revenue
2.19T
Ranking
n/a
PE Ratio
38.58
Stock Price
100,300.00
Market Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 7.45T, an increase of 3,115.83%. That is a compound annual growth rate of 14.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 7.45T | -11.19% |
| Dec 30, 2025 | 8.39T | -6.18% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 6.73T |
| Hanall Biopharma | 2.82T |
| Celltrion Pharm | 2.70T |
| Daewoong Pharmaceutical | 1.84T |
| GC Biopharma | 1.66T |
| Chong Kun Dang Pharmaceutical | 1.16T |
| Daewoong | 989.56B |
| Ildong Pharmaceutical | 989.35B |